The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 116,600 |
| Depreciation and amortization | 43,600 |
| Adjustment to fair value of contingent consideration | -15,900 |
| Impairment of property, plant and equipment | 22,900 |
| Impairment of intangible assets | 19,100 |
| Deferred taxes | -10,200 |
| Profit on disposal of property, plant and equipment | 200 |
| Non-cash movements of defined benefit pension plans | 2,700 |
| Stock option compensation | 8,100 |
| Trade and other accounts receivable | -21,600 |
| Inventories | 6,600 |
| Prepaid expenses | -1,800 |
| Accounts payable and accrued liabilities | -32,800 |
| Plant closure provisions | -1,900 |
| Accrued income taxes | -21,800 |
| Unrecognized tax benefits | 0 |
| Other assets and liabilities | 8,700 |
| Net cash provided by operating activities | 138,300 |
| Capital expenditures | 50,300 |
| Proceeds on disposal of property, plant and equipment | 1,100 |
| Business combinations, net of cash acquired | 700 |
| Internally developed software | 25,200 |
| Net cash used in investing activities | -75,100 |
| Non-controlling interest | 1,900 |
| Repayment of term loan | 0 |
| Refinancing costs | 0 |
| Dividend paid | 42,400 |
| Issue of treasury stock | 500 |
| Repurchase of common stock | 23,900 |
| Net cash used in financing activities | -63,900 |
| Effect of foreign currency exchange rate changes on cash | 4,000 |
| Net change in cash and cash equivalents | 3,300 |
| Cash and cash equivalents at beginning of period | 289,200 |
| Cash and cash equivalents at end of period | 292,500 |
INNOSPEC INC. (IOSP)
INNOSPEC INC. (IOSP)